ClinicalTrials.Veeva

Menu

Surgiphor vs Saline Joints

C

Center for Innovation and Research Organization

Status

Invitation-only

Conditions

Prosthetic-joint Infection

Treatments

Device: Sterile saline
Device: Surgiphor Irrigation Solution

Study type

Interventional

Funder types

NETWORK

Identifiers

NCT05434260
Surgiphor01

Details and patient eligibility

About

This study will be an open-label superiority, multicenter, single-blind, controlled randomized clinical trial investing the role of a PVP-I irrigation solution (Surgiphor) in reducing the risk of acute PJI in the 90 days following total hip and knee revision arthroplasty.

Enrollment

868 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patient ≥18 years old
  2. Male or non-pregnant, non-lactating, postmenopausal or surgically sterilized females
  3. Subjects scheduled to undergo total knee or total hip revision for aseptic reasons (per 2018 ICM criteria 5)
  4. Subjects provide informed consent, which will consist of reading, signing, and dating the informed consent document after the Investigator, sub-Investigator or other designated study staff member has explained the study procedures, risks, and contact information. Subjects not willing to sign consent form to be randomized must be willing to sign alternate consent form to allow prospective data collection in the non-randomized arm of the study

Exclusion criteria

  1. Subjects with known allergies to iodine or any other ingredients in Surgiphor
  2. Subjects unwilling to sign informed consent
  3. Subjects, for health reasons or other, in the opinion of the Investigator, with a life expectancy less than one year, which is the follow-up period of the study

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

868 participants in 2 patient groups, including a placebo group

Surgiphor: sterile povidone iodine irrigation solution
Active Comparator group
Description:
Surgiphor Wound Irrigation Solution, bottle consisting of sterile 0.5% PVP-I formulation with 0.9% saline, Potassium Iodide, Phosphate Buffer, Vitamin E TPGS
Treatment:
Device: Surgiphor Irrigation Solution
Sterile saline
Placebo Comparator group
Treatment:
Device: Sterile saline

Trial contacts and locations

4

Loading...

Central trial contact

Tiffany Morrison, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems